Hennepin Healthcare starts trials on antiviral drug showing promise with severe COVID-19 cases

A drug that is showing some early success in treating severe cases of COVID-19 is now being studied in trials by Hennepin Healthcare. The Hennepin Healthcare Research Institute has launched two trials to study the safety of remdesivir.